We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Simple Blood Tests Improve Hypertension Treatment

By LabMedica International staff writers
Posted on 17 May 2017
Print article
African and African American hypertensives tend to retain salt and water, with lower levels of plasma renin and more resistant hypertension. Two simple blood tests were able to drastically improve treatment for resistant hypertension across three sites in Nigeria, Kenya and South Africa.

By testing patients' levels of plasma renin, a protein secreted by the kidneys, in combination with levels of aldosterone, a hormone that causes salt and water retention, physicians were able to identify the physiological changes causing the hypertension. This led to personalized and more accurate therapy.

An international team of scientists under the auspices of Western University enrolled patients at hypertension clinics in Nigeria, Kenya, and South Africa with a systolic blood pressure greater than140 mm Hg or diastolic pressure greater than 90 mm Hg despite treatment were allocated to usual care (UC) versus physiologically individualized care (PhysRx). Plasma renin activity and aldosterone were measured using enzyme-linked immunosorbent assay (ELISA) kits. Patients were followed for one year; the primary outcome was the percentage of patients achieving blood pressure less than140 mm Hg and diastolic less than 90 mm Hg.

Of the 94 patients who completed the study, 42 were treated with the usual course of treatment, 52 were given the blood tests, and treatment was decided based on the results. In the group who were given usual treatment, 11.1% had controlled blood pressure after one year, versus 50% in the group that received the blood test. Systolic control was achieved in 13.9% of UC versus 60.3% of PhysRx; diastolic control in 36.1% of UC versus 67.2% of PhysRx.

The authors concluded that physiologically individualized therapy based on renin/aldosterone phenotyping significantly improved blood pressure control in a sample of African patients with uncontrolled hypertension. This approach should be tested in African American and other patients with resistant hypertension. J. David Spence, MBA, MD, FRCPC, a professor and lead investigator of the study said, “"If a patient has salt and water retention, it causes high blood pressure and also feeds back and shuts down both renin and aldosterone.” The study was published on May 2, 2017, in the American Journal of Hypertension.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.